Metformin encapsulated gold nanoparticles (MTF‐GNPs): A promising antiglycation agent
The generation of advanced glycation end products (AGEs) through nonenzymatic protein
glycation contributes to the pathogenesis of long‐lived diabetic problems. Metformin (MTF) …
glycation contributes to the pathogenesis of long‐lived diabetic problems. Metformin (MTF) …
Metformin encapsulated gold nanoparticles (MTF-GNPs): A promising antiglycation agent.
F Alenazi, M Saleem, ASS Khaja, M Zafar… - Cell Biochemistry and …, 2022 - europepmc.org
The generation of advanced glycation end products (AGEs) through nonenzymatic protein
glycation contributes to the pathogenesis of long-lived diabetic problems. Metformin (MTF) is …
glycation contributes to the pathogenesis of long-lived diabetic problems. Metformin (MTF) is …
Metformin encapsulated gold nanoparticles (MTF-GNPs): A promising antiglycation agent
F Alenazi, M Saleem, ASS Khaja… - Cell biochemistry …, 2022 - pubmed.ncbi.nlm.nih.gov
The generation of advanced glycation end products (AGEs) through nonenzymatic protein
glycation contributes to the pathogenesis of long-lived diabetic problems. Metformin (MTF) is …
glycation contributes to the pathogenesis of long-lived diabetic problems. Metformin (MTF) is …
Metformin encapsulated gold nanoparticles (MTF‐GNPs): A promising antiglycation agent.
F Alenazi, M Saleem, ASS Khaja… - Cell Biochemistry & …, 2022 - search.ebscohost.com
The generation of advanced glycation end products (AGEs) through nonenzymatic protein
glycation contributes to the pathogenesis of long‐lived diabetic problems. Metformin (MTF) …
glycation contributes to the pathogenesis of long‐lived diabetic problems. Metformin (MTF) …
Metformin encapsulated gold nanoparticles (MTF‐GNPs): A promising antiglycation agent
F Alenazi, M Saleem, ASS Khaja… - Cell Biochemistry …, 2022 - Wiley Online Library
The generation of advanced glycation end products (AGEs) through nonenzymatic protein
glycation contributes to the pathogenesis of long‐lived diabetic problems. Metformin (MTF) …
glycation contributes to the pathogenesis of long‐lived diabetic problems. Metformin (MTF) …
[PDF][PDF] Metformin encapsulated gold nanoparticles (MTF‐GNPs): A promising antiglycation agent
F Alenazi, M Saleem, ASS Khaja, M Zafar, MS Alharbi… - researchgate.net
The generation of advanced glycation end products (AGEs) through nonenzymatic protein
glycation contributes to the pathogenesis of long‐lived diabetic problems. Metformin (MTF) …
glycation contributes to the pathogenesis of long‐lived diabetic problems. Metformin (MTF) …
Metformin encapsulated gold nanoparticles (MTF‐GNPs): A promising antiglycation agent
F Alenazi, M Saleem, ASS Khaja, M Zafar… - Cell Biochemistry and …, 2022 - infona.pl
The generation of advanced glycation end products (AGEs) through nonenzymatic protein
glycation contributes to the pathogenesis of long‐lived diabetic problems. Metformin (MTF) …
glycation contributes to the pathogenesis of long‐lived diabetic problems. Metformin (MTF) …